about
Identification and characterization of a novel protein ISOC2 that interacts with p16INK4aExtracellular microRNAs in urologic malignancies: chances and challengesM-HIFU inhibits tumor growth, suppresses STAT3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancereRNA: a graphic user interface-based tool optimized for large data analysis from high-throughput RNA sequencing.Increased platelet distribution width predicts poor prognosis in melanoma patientsCirculating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axisExosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancerProstate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome.Characterization of human plasma-derived exosomal RNAs by deep sequencing.CPA-7 influences immune profile and elicits anti-prostate cancer effects by inhibiting activated STAT3.Plasma extracellular RNA profiles in healthy and cancer patients.Aberrant regulation of miR-15b in human malignant tumors and its effects on the hallmarks of cancer.Gallstone disease is associated with arterial stiffness progression.Combined evaluation of the expression of NUCKS and Ki-67 proteins as independent prognostic factors for patients with gastric adenocarcinoma.pCREB is involved in neural induction of mouse embryonic stem cells by RA.Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).Role of exosomal small RNA in prostate cancer metastasisPlatelet Indices in Colorectal Cancer Patients with Synchronous Liver MetastasesThe versatile roles and clinical implications of exosomal mRNAs and microRNAs in cancer
P50
Q24322656-77A800C9-2F9F-46BB-AE59-3BF17F1F365AQ26866043-B79E296B-814D-42EA-9D0A-41EE83F59411Q30465410-1A20AAB3-7CF9-4E50-9FC1-605AEFA47EFFQ30769819-0BE5D9DD-6EAC-41AD-8459-CC7859544453Q33774185-3A06B947-F7FD-46BD-ABB7-F6CC0F2B94D6Q33829967-78843A95-E842-4BF1-8982-FC4BA49F59FBQ33830016-2973597A-159E-4932-88A4-CEA10C2EEFE3Q34614989-0A566E5F-A038-4D87-85A5-418EF3E8179EQ34673469-77190869-6870-4A52-A072-4219AA1B58AEQ34714581-1C417183-A0C6-45E4-96E6-A85431C5BECDQ36082118-EDBB2485-A048-40AD-8988-770DA3612424Q36501082-DF44D588-3D73-4861-982D-CC34899BAF4FQ38639540-73A9C73D-74ED-45C4-BF6D-99DC4EE45B16Q40563764-2ACB41A9-8C2D-4CEA-82AE-759F7E397AB1Q45077435-5036613C-9173-403B-B231-4B626935B73BQ46668799-7B66D601-04AC-4A3D-9066-0104D360C58EQ48721044-932D57B5-1306-492A-9695-B3A2154C5A3EQ57489975-D0DE6352-D532-4076-A1F9-EB01D7B225D3Q91529521-3A3EF6DD-9747-43DE-A9DB-B59CFDF51C7EQ94598831-E73ABBAB-4FD5-4AAD-A4F1-CF6CE9B64718
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Xiaoyi Huang
@en
Xiaoyi Huang
@nl
type
label
Xiaoyi Huang
@en
Xiaoyi Huang
@nl
prefLabel
Xiaoyi Huang
@en
Xiaoyi Huang
@nl
P31
P496
0000-0002-2355-5688